Diabetes – Natural Treatment
By Dorothy M. Neddermeyer, PhD
Jose M. Flores, a Medicare beneficiary who lives outside McAllen, used the new drug benefit four times from January to April to purchase Byetta, an injectable medicine for diabetes. Each time he paid $40.
So when he went to the pharmacy on May 25, he was dismayed to be told that he owed $167.56 for the next month’s supply. Mr. Flores had reached the notorious gap in Medicare’s drug coverage. He had to pay the full price of Byetta. His Medicare drug plan paid nothing.
“It’s almost useless,” said Mr. Flores, a 66-year-old school bus mechanic who was interviewed at his home in La Joya, Tex. “I’m paying the premium, but not getting protection.”
Millions of beneficiaries will have similar experiences, as the cost of their drugs reaches the initial coverage limit of $2,250. Like Mr. Flores, they will have to pay the full cost of each medicine until their out-of-pocket costs reach $3,600. At that point, Medicare coverage resumes, paying 95 percent of the cost of each prescription.